Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor Academic Article uri icon

Overview

MeSH Major

  • Human Growth Hormone
  • Neoplasms, Second Primary

abstract

  • Although cancer survivors treated with GH appear to have an increased risk of developing SN compared with survivors not so treated, the elevation of risk due to GH use appears to diminish with increasing length of follow-up. Continued surveillance is essential.

publication date

  • September 22, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1210/jc.2006-0656

PubMed ID

  • 16822820

Additional Document Info

start page

  • 3494

end page

  • 8

volume

  • 91

number

  • 9